Combination Therapy in Cancers With Mutations in DNA Repair Genes
Condition(s):Metastatic Solid Tumor; BRCA1 Mutation; BRCA2 Mutation; ATM Gene Mutation; PALB2 Gene MutationLast Updated:November 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Solid Tumor; BRCA1 Mutation; BRCA2 Mutation; ATM Gene Mutation; PALB2 Gene MutationLast Updated:November 13, 2023Recruiting
Condition(s):Ovarian CancerLast Updated:March 10, 2021Withdrawn
Condition(s):Ovarian CancerLast Updated:August 18, 2020Terminated
Condition(s):Recurrent Ovarian Cancer; Recurrent Fallopian Tube Cancer; Primary Peritoneal CancerLast Updated:July 27, 2022Not yet recruiting
Condition(s):Ovarian Cancer; HRD; PARP InhibitorLast Updated:September 14, 2021Unknown status
Condition(s):Ovarian NeoplasmLast Updated:October 5, 2020Completed
Condition(s):Advanced Solid TumorsLast Updated:June 8, 2023Completed
Condition(s):Breast CancerLast Updated:May 30, 2023Active, not recruiting
Condition(s):Ovarian Cancer RecurrentLast Updated:June 7, 2023Withdrawn
Condition(s):Ovarian CancerLast Updated:February 25, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.